These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule. Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905 [TBL] [Abstract][Full Text] [Related]
31. Correlation of alkaline phosphatase staining of cortisol-producing adrenocortical tumors with dexamethasone suppression and ACTH stimulation. Aiba M Acta Pathol Jpn; 1977 Nov; 27(6):877-91. PubMed ID: 204155 [TBL] [Abstract][Full Text] [Related]
32. [Clinical and preclinical aspects of adrenal Cushing syndrome]. Ambrosi B; Re T; Passini E; Peverelli S; Sartorio A; Colombo P Minerva Endocrinol; 1995 Mar; 20(1):39-47. PubMed ID: 7651281 [TBL] [Abstract][Full Text] [Related]
33. [Cushing's syndrome: diagnostic exploration]. Tabarin A; Roger P Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815 [TBL] [Abstract][Full Text] [Related]
34. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765 [TBL] [Abstract][Full Text] [Related]
35. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome. Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428 [TBL] [Abstract][Full Text] [Related]
36. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy. Warren SE; Westbie DK; Daly R; Bower RH South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547 [TBL] [Abstract][Full Text] [Related]
37. Adrenal suppression and cushingoid changes secondary to dexamethasone nose drops. Heroman WM; Bybee DE; Cardin J; Bass JW; Johnsonbaugh RE J Pediatr; 1980 Mar; 96(3 Pt 1):500-1. PubMed ID: 7188955 [No Abstract] [Full Text] [Related]
38. Diagnosis of canine Cushing's syndrome based on multiple steroid analysis and dexamethasone turnover kinetics. Lothrop CD; Oliver JW Am J Vet Res; 1984 Nov; 45(11):2304-9. PubMed ID: 6098199 [TBL] [Abstract][Full Text] [Related]
39. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [TBL] [Abstract][Full Text] [Related]
40. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland. Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]